Overview

This trial is active, not recruiting.

Condition thyroid diseases
Treatments chinese herbs-i, chinese herbs-ii
Phase phase 1/phase 2
Sponsor Tianjin Medical University Cancer Institute and Hospital
Start date June 2012
End date October 2016
Trial size 400 participants
Trial identifier NCT01873014, head2012neck

Summary

safe study of Chinese Herbs to Treat Thyroid Diseases With Different Iodine

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation randomized
Endpoint classification safety/efficacy study
Intervention model parallel assignment
Masking open label
Primary purpose treatment
Arm
(Experimental)
chinese herbs-i
two agent per day, twice a day
(Active Comparator)
chinese herbs-ii
two agent per day, twice a day

Primary Outcomes

Measure
diameter,number of the tumor
time frame: 3 months

Eligibility Criteria

Male or female participants from 18 years up to 70 years old.

Inclusion Criteria: - patient with thyroid diseases Exclusion Criteria: - not meet the diagnostic criteria,women with pregnancy or lactation ,drug allergy ,need surgery

Additional Information

Official title the Effect of Chinese Herbs to Treat Thyroid Diseases With Different Iodine Intake
Description Based on the previous studies, the research choose the patients with different iodine intake,and improve our original Chinese Herbs thyroid III formula, in order to provide the patients the best individual treatment plan.
Trial information was received from ClinicalTrials.gov and was last updated in February 2016.
Information provided to ClinicalTrials.gov by Tianjin Medical University Cancer Institute and Hospital.